A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing study

BACKGROUND: Perioperative chemotherapy (ChT) and preoperative chemoradiation (CRT) are both the standard treatments for locally advanced gastric cancer (LAGC). CRT can achieve a higher pathological complete regression (pCR) rate, but whether this higher pCR rate can be transformed into a long-term s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Menglong, Yang, Wang, Xuan, Yan, Zou, Wei, Wang, Yaqi, Zhang, Zhiyuan, Zhang, Jing, Mo, Miao, Zhou, Changming, Liu, Yuan, Zhang, Wenming, Zhang, Zhaozhen, He, Yiping, Weng, Weiwei, Tan, Cong, Wang, Lei, Huang, Dan, Sheng, Weiqi, Li, Huanhuan, Zhu, Hui, Wang, Yan, Shen, Lijun, Zhang, Hui, Wan, Juefeng, Li, Guichao, Huang, Hua, Wang, Yanong, Zhang, Zhen, Liu, Xiaowen, Xia, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238164/
https://www.ncbi.nlm.nih.gov/pubmed/35764956
http://dx.doi.org/10.1186/s12885-022-09786-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238164/
https://www.ncbi.nlm.nih.gov/pubmed/35764956
http://dx.doi.org/10.1186/s12885-022-09786-9

Ejemplares similares